Jun 11, 2025
Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Apr 14, 2025
Evofem Biosciences to Present at Emerging Growth Conference
Mar 26, 2025
Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics
Feb 13, 2025
Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO
Nov 06, 2024
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Aug 20, 2024
Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
Aug 14, 2024
Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
Jul 23, 2024
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
Jun 27, 2024
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare
Apr 18, 2024
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO
Mar 20, 2024
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal
Mar 07, 2024
For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
Feb 01, 2024
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
Jan 08, 2024
Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game
Feb 23, 2021
Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference
Feb 18, 2021
Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021
Feb 16, 2021
Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women
Feb 04, 2021
Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®, A Non-Hormonal Birth Control Option for Women with Cancer
Jan 12, 2021
Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021
Dec 17, 2020
Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea